Opinion: The FDA had the right to approve aducanumab for Alzheimer's disease

Is a researcher and director of FDAReview.org at the Independent Institute in Oakland, California, and an assistant professor of agricultural business and …

Continue

Do you trust this headline?

Based on recent headline ratings, 69% of this readership currently trusts the local media, which has an average score of 84% regionally and is currently trending negative.

69%

Media Trust Score69%

Read All

In

News